These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 39113803)

  • 1. Biomimetic nanoparticles with enhanced rapamycin delivery for autism spectrum disorder treatment via autophagy activation and oxidative stress modulation.
    Miao C; Shen Y; Lang Y; Li H; Gong Y; Liu Y; Li H; Jones BC; Chen F; Feng S
    Theranostics; 2024; 14(11):4375-4392. PubMed ID: 39113803
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral edaravone ameliorates behavioral deficits and pathologies in a valproic acid-induced rat model of autism spectrum disorder.
    Lu XY; Li MQ; Li YT; Yao JY; Zhang LX; Zeng ZH; Yu-Liu ; Chen ZR; Li CQ; Zhou XF; Li F
    Neuropharmacology; 2024 Nov; 258():110089. PubMed ID: 39033904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of agomelatine in behavioral, neurochemical and blood brain barrier alterations in prenatal valproic acid induced autism spectrum disorder.
    Kumar H; Sharma BM; Sharma B
    Neurochem Int; 2015 Dec; 91():34-45. PubMed ID: 26498253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium Hexacyanoferrate (III) Nanocatalyst Enables Redox Homeostasis for Autism Spectrum Disorder Treatment.
    Feng S; Gong Y; Xia L; Lang Y; Shen Y; Li H; Feng W; Chen F; Chen Y
    Adv Mater; 2024 Sep; 36(39):e2405655. PubMed ID: 39096109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delivery of rapamycin by biomimetic peptide nanoparticles targeting oxidized low-density lipoprotein in atherosclerotic plaques.
    Wang A; Yue K; Zhong W; Zhang G; Wang L; Zhang H; Zhang X
    Biomater Sci; 2024 Aug; 12(16):4181-4193. PubMed ID: 38979569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute rapamycin rescues the hyperexcitable phenotype of accumbal medium spiny neurons in the valproic acid rat model of autism spectrum disorder.
    Iezzi D; Curti L; Ranieri G; Gerace E; Costa A; Ilari A; La Rocca A; Luceri C; D'Ambrosio M; Silvestri L; Scardigli M; Mannaioni G; Masi A
    Pharmacol Res; 2022 Sep; 183():106401. PubMed ID: 35987482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delving into the Complexity of Valproate-Induced Autism Spectrum Disorder: The Use of Zebrafish Models.
    Camussi D; Naef V; Brogi L; Della Vecchia S; Marchese M; Nicoletti F; Santorelli FM; Licitra R
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioengineering CXCR4-overexpressing cell membrane functionalized ROS-responsive nanotherapeutics for targeting cerebral ischemia-reperfusion injury.
    Luo L; Zang G; Liu B; Qin X; Zhang Y; Chen Y; Zhang H; Wu W; Wang G
    Theranostics; 2021; 11(16):8043-8056. PubMed ID: 34335979
    [No Abstract]   [Full Text] [Related]  

  • 10. Neuronal mitochondria-targeted therapy for Alzheimer's disease by systemic delivery of resveratrol using dual-modified novel biomimetic nanosystems.
    Han Y; Chu X; Cui L; Fu S; Gao C; Li Y; Sun B
    Drug Deliv; 2020 Dec; 27(1):502-518. PubMed ID: 32228100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphodiesterase inhibitor, ibudilast alleviates core behavioral and biochemical deficits in the prenatal valproic acid exposure model of autism spectrum disorder.
    Sandhu A; Rawat K; Gautam V; Sharma A; Kumar A; Saha L
    Brain Res; 2023 Sep; 1815():148443. PubMed ID: 37290608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin A ameliorates valproic acid-induced autism-like symptoms in developing zebrafish larvae by attenuating oxidative stress and apoptosis.
    Wang J; Zou L; Jiang P; Yao M; Xu Q; Hong Q; Zhu J; Chi X
    Neurotoxicology; 2024 Mar; 101():93-101. PubMed ID: 38191030
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapamycin-Loaded Biomimetic Nanoparticles Reverse Vascular Inflammation.
    Boada C; Zinger A; Tsao C; Zhao P; Martinez JO; Hartman K; Naoi T; Sukhoveshin R; Sushnitha M; Molinaro R; Trachtenberg B; Cooke JP; Tasciotti E
    Circ Res; 2020 Jan; 126(1):25-37. PubMed ID: 31647755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified Ce/Zr-MOF Nanoparticles Loaded with Curcumin for Alzheimer's Disease via Multifunctional Modulation.
    Yang Y; Wang Y; Jiang X; Mi J; Ge D; Tong Y; Zhu Y
    Int J Nanomedicine; 2024; 19():9943-9959. PubMed ID: 39355653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotective effect of Diosgenin in the rat Valproic acid model of autism.
    Reza Naghdi M; Ahadi R; Motamed Nezhad A; Sadat Ahmadi Tabatabaei F; Soleimani M; Hajisoltani R
    Brain Res; 2024 Sep; 1838():148963. PubMed ID: 38705555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of rapamycin on social interaction deficits and gene expression in mice exposed to valproic acid in utero.
    Kotajima-Murakami H; Kobayashi T; Kashii H; Sato A; Hagino Y; Tanaka M; Nishito Y; Takamatsu Y; Uchino S; Ikeda K
    Mol Brain; 2019 Jan; 12(1):3. PubMed ID: 30621732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cilostazol attenuated prenatal valproic acid-induced behavioural and biochemical deficits in a rat model of autism spectrum disorder.
    Luhach K; Kulkarni GT; Singh VP; Sharma B
    J Pharm Pharmacol; 2021 Oct; 73(11):1460-1469. PubMed ID: 34459916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative effectiveness of metformin and risperidone in a rat model of valproic acid-induced autism, Potential role for enhanced autophagy.
    Atia AA; Ashour RH; Zaki MM; Rahman KM; Ramadan NM
    Psychopharmacology (Berl); 2023 Jun; 240(6):1313-1332. PubMed ID: 37133558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features.
    Zhou L; Jiang P; Zhao L; Fei X; Tang Y; Luo Y; Gong H; Wang X; Li X; Li S; Zhang C; Yang H; Fan X
    Phytomedicine; 2024 Apr; 126():155443. PubMed ID: 38394737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lutein-loaded nanoparticles reverse oxidative stress, apoptosis, and autism spectrum disorder-like behaviors induced by prenatal valproic acid exposure in female rats.
    Viana CE; Bortolotto VC; Araujo SM; Dahleh MMM; Machado FR; de Souza Pereira A; Moreira de Oliveira BP; Leimann FV; Gonçalves OH; Prigol M; Guerra GP
    Neurotoxicology; 2023 Jan; 94():223-234. PubMed ID: 36528186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.